Search Results - "NAGAHARA, SHUNJI"

Refine Results
  1. 1

    Systemic delivery of siRNA specific to tumor mediated by atelocollagen: Combined therapy using siRNA targeting Bcl‐xL and cisplatin against prostate cancer by Mu, Ping, Nagahara, Shunji, Makita, Naoki, Tarumi, Yuzo, Kadomatsu, Kenji, Takei, Yoshifumi

    Published in International journal of cancer (15-12-2009)
    “…The largest obstacle to the effective use of short interfering RNA (siRNA) in an animal body is the ability to deliver it to the target tissue. Here we showed…”
    Get full text
    Journal Article
  2. 2
  3. 3

    Downregulation of Monocyte Chemoattractant Protein-1 Involving Short Interfering RNA Attenuates Hapten-induced Contact Hypersensitivity by Ishimoto, Takuji, Takei, Yoshifumi, Yuzawa, Yukio, Hanai, Koji, Nagahara, Shunji, Tarumi, Yuzo, Matsuo, Seiichi, Kadomatsu, Kenji

    Published in Molecular therapy (01-02-2008)
    “…Contact hypersensitivity (CHS) is a common skin disease, presenting clinically as allergic contact dermatitis. At inflammatory sites in a typical CHS model in…”
    Get full text
    Journal Article
  4. 4

    Atelocollagen-Mediated Systemic DDS for Nucleic Acid Medicines by HANAI, KOJI, TAKESHITA, FUMITAKA, HONMA, KIMI, NAGAHARA, SHUNJI, MAEDA, MIHO, MINAKUCHI, YOSHIKO, SANO, AKIHIKO, OCHIYA, TAKAHIRO

    Published in Annals of the New York Academy of Sciences (01-10-2006)
    “…:  The goal of our research is to provide a practical platform for drug delivery in oligonucleotide therapy. We report here the efficacy of an…”
    Get full text
    Journal Article
  5. 5

    Biomaterials for gene delivery: atelocollagen-mediated controlled release of molecular medicines by Ochiya, T, Nagahara, S, Sano, A, Itoh, H, Terada, M

    Published in Current gene therapy (01-05-2001)
    “…Over the last decade, increasing attention has been paid to the development of systems to deliver drugs for long periods at controlled rates. Some of these…”
    Get more information
    Journal Article
  6. 6

    Atelocollagen-Based Gene Transfer in Cells Allows High-Throughput Screening of Gene Functions by Honma, Kimi, Ochiya, Takahiro, Nagahara, Shunji, Sano, Akihiko, Yamamoto, Hanako, Hirai, Kotaro, Aso, Yu, Terada, Masaaki

    “…We have previously demonstrated that Atelocollagen, used clinically for wound healing, is a reliable safe carrier for gene delivery. To obtain phenotypic…”
    Get full text
    Journal Article
  7. 7

    Single‐injection ornithine decarboxylase‐directed antisense therapy using atelocollagen to suppress human cancer growth by Nakazawa, Kunihiko, Nemoto, Takahiro, Hata, Tomoko, Seyama, Yousuke, Nagahara, Shunji, Sano, Akihiko, Itoh, Hiroshi, Nagai, Yutaka, Kubota, Shunichiro

    Published in Cancer (01-03-2007)
    “…BACKGROUND Substantial evidence supports a direct role of ornithine decarboxylase (ODC) in the development and maintenance of human tumors. Although antisense…”
    Get full text
    Journal Article
  8. 8

    Potential of atelocollagen-mediated systemic antisense therapeutics for inflammatory disease by Hanai, Koji, Kurokawa, Tomoyo, Minakuchi, Yoshiko, Maeda, Miho, Nagahara, Shunji, Miyata, Teruo, Ochiya, Takahiro, Sano, Akihiko

    Published in Human gene therapy (01-03-2004)
    “…To study the possibility of using atelocollagen as an oligonucleotide (ODN) delivery carrier in vivo, the activity of formulated antisense ODN targeted against…”
    Get more information
    Journal Article
  9. 9

    RPN2 gene confers docetaxel resistance in breast cancer by Ochiya, Takahiro, Honma, Kimi, Iwao-Koizumi, Kyoko, Takeshita, Fumitaka, Yamamoto, Yusuke, Yoshida, Teruhiko, Nishio, Kazuto, Nagahara, Shunji, Kato, Kikuya

    Published in Nature medicine (01-09-2008)
    “…Resistance to drugs is a clinical problem. Downregulating the gene RPN2 , which encodes part of an N -oligosaccharyl transferase complex, sensitized breast…”
    Get full text
    Journal Article
  10. 10

    Atelocollagen-mediated Systemic Delivery Prevents Immunostimulatory Adverse Effects of siRNA in Mammals by Inaba, Shinichiro, Nagahara, Shunji, Makita, Naoki, Tarumi, Yuzo, Ishimoto, Takuji, Matsuo, Seiichi, Kadomatsu, Kenji, Takei, Yoshifumi

    Published in Molecular therapy (01-02-2012)
    “…Short interfering RNA (siRNA) is a potent activator of the mammalian innate immune system. When considering possible clinical applications of siRNA for humans,…”
    Get full text
    Journal Article
  11. 11

    Atelocollagen-mediated synthetic small interfering RNA delivery for effective gene silencing in vitro and in vivo by Minakuchi, Yoshiko, Takeshita, Fumitaka, Kosaka, Nobuyoshi, Sasaki, Hideo, Yamamoto, Yusuke, Kouno, Makiko, Honma, Kimi, Nagahara, Shunji, Hanai, Koji, Sano, Akihiko, Kato, Takashi, Terada, Masaaki, Ochiya, Takahiro

    Published in Nucleic acids research (01-01-2004)
    “…Silencing gene expression by siRNAs is rapidly becoming a powerful tool for the genetic analysis of mammalian cells. However, the rapid degradation of siRNA…”
    Get full text
    Journal Article
  12. 12

    Atelocollagen for protein and gene delivery by Sano, Akihiko, Maeda, Miho, Nagahara, Shunji, Ochiya, Takahiro, Honma, Kimi, Itoh, Hiroshi, Miyata, Teruo, Fujioka, Keiji

    Published in Advanced drug delivery reviews (28-11-2003)
    “…Recent progress in recombinant gene technology and cell culture technology has made it possible to use protein and polynucleotides as effective drugs. However,…”
    Get full text
    Journal Article
  13. 13

    New delivery system for plasmid DNA in vivo using atelocollagen as a carrier material: the Minipellet by Terada, Masaaki, Ochiya, Takahiro, Takahama, Yasushi, Nagahara, Shunji, Sumita, Yoshihiro, Hisada, Akihiko, Itoh, Hiroshi, Nagai, Yutaka

    Published in Nature medicine (01-06-1999)
    “…Skeletal muscle is a likely site for the delivery and expression of exogenous genes, both to treat local diseases and to act as a `bioreactor' for producing…”
    Get full text
    Journal Article
  14. 14
  15. 15

    Correction: Corrigendum: RPN2 gene confers docetaxel resistance in breast cancer by Honma, Kimi, Iwao-Koizumi, Kyoko, Takeshita, Fumitaka, Yamamoto, Yusuke, Yoshida, Teruhiko, Nishio, Kazuto, Nagahara, Shunji, Kato, Kikuya, Ochiya, Takahiro

    Published in Nature medicine (01-10-2008)
    “…Nat. Med. 14, 939–948 (2008); published online 17 August 2008; corrected after print 7 October 2008 In the version of this article initially published, the…”
    Get full text
    Journal Article
  16. 16
  17. 17

    Hydrogel formation via hybridization of oligonucleotides derivatized in water-soluble vinyl polymers by Nagahara, Shunji, Matsuda, Takehisa

    Published in Polymer gels and networks (1996)
    “…Succinimido-copolymers, poly(N,N-dimethylacrylamide-co-N-acryloyloxysuccinimide)s, were coupled with 5′-terminal-amino-modified oligodeoxyribonucleotides…”
    Get full text
    Journal Article
  18. 18

    199. Efficient Inhibition of Bone Metastasis Via Systemic Delivery of siRNA Using Atelocollagen-Mediated Delivery System by Nagahara, Shunji, Takeshita, Fumitaka, Honma, Kimi, Minakuchi, Yoshiko, Sano, Akihiko, Ochiya, Takahiro

    Published in Molecular therapy (01-05-2005)
    “…RNA interference has been one of the most powerful tool for genetic analysis, and much research on the development of siRNA for therapeutic use has progressed…”
    Get full text
    Journal Article
  19. 19

    830. Efficient Transfer of Synthetic Small Interfering RNAs through Atelocollagen-Mediated Delivery System by Nagahara, Shunji, Minakuchi, Yoshiko, Takeshita, Fumitaka, Honma, Kimi, Hanai, Koji, Sano, Akihiko, Ochiya, Takahiro

    Published in Molecular therapy (01-05-2004)
    “…Since it was observed that RNA interference which is an autologous protecting and regulating mechanism of eukaryotes can be worked artificially by introducing…”
    Get full text
    Journal Article
  20. 20